This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (33)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Critical Review of Studies

Francisco D. Cervantes, MD; Lawrence J. Schneiderman, MD

Arch Intern Med. 1975;135(6):875-877.

Abstract
Anticoagulant therapy in the treatment of cerebral thromboembolism remains controversial despite 20 years of statistical studies. Among the unresolved questions are (1) the relative value of aspirin vs coumarin derivatives for long-term therapy; (2) the relative benefits of long-term therapy vs short-term therapy; (3) the complications of anticoagulant therapy vs their therapeutic benefits; and (4) the optimal therapy of the various types of cerebral thromboembolic events, eg, transient ischemic attacks, strokes in evolution, and completed strokes.

Much of this controversy derives from the same problems that have plagued the question of anticoagulation for acute myocardial infarction, namely that "the existing statistics were obtained without adequate attention to fundamental principles of clinical science." We have examined the available clinical studies bearing on this issue and are reporting our analysis of these studies.

Author Affiliations
From the departments of community medicine and medicine, University of California at San Diego School of Medicine, La Jolla.

Footnotes
Received for publication Dec 5,1974; accepted Jan 6, 1975.

Reprint requests to Box 109, S-004, La Jolla, CA 92037 (Dr. Schneiderman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The (Alternative) Medicalization of Life
Schneiderman
J Law Med Ethics 2003;31:191-197.
 

How Twin Cities Neurologists Treat Ischemic Stroke: Policies and Trends
Anderson
Arch Neurol 1993;50:1098-1103.
ABSTRACT  

Stroke: The Use and Overuse of Heparin in Therapeutic Trials
Sage
Arch Neurol 1985;42:315-317.
ABSTRACT  

Controlled Trial of Ancrod in Ischemic Stroke
Hossmann et al.
Arch Neurol 1983;40:803-808.
ABSTRACT  

Therapy of Ischemic Cerebrovascular Disease
BYER and EASTON
ANN INTERN MED 1980;93:742-756.
ABSTRACT  

Superior Sagittal Sinus Thrombosis-Reply
Gettelfinger and Kokmen
Arch Neurol 1977;34:789-789.
ABSTRACT  

Cooperative Study of Hospital Frequency and Character of Transient Ischemic Attacks: III. Variations in Treatment
Haerer et al.
JAMA 1977;238:142-146.
ABSTRACT